University of Oxford resumes vaccine trials after pause
Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after a pause due to a reported side effect in a patient in the UK.
Full Article
University of Oxford resumes vaccine trials after pause
Belfast Telegraph
0 shares
1 views
You might like
Related news coverage
Serum Institute CEO lauds PM Narendra Modi's COVID-19 vaccine vision day after challenging Centre on pandemic response
DNA
It is to be noted that the Serum Institute of India is all set to begin phase three trials of the Covishield Vaccine developed by..
Advertisement
More coverage
Questions raised about taking future Coronavirus vaccine
Gloucester Citizen
Several vaccines are hoped to be in clinical trials by the end of the year, including one at the University of Oxford
-
COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan
Mid-Day
-
News24.com | Covid-19: Wits resumes participation in the Oxford's vaccine trials
News24
-
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Mid-Day
-
'AstraZeneca hasn't resumed trial in US'
Mid-Day